What is the share price of Nureca Ltd (NURECA) today?
The share price of NURECA as on 11th July 2025 is ₹286.65. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Nureca Ltd (NURECA) share?
The past returns of Nureca Ltd (NURECA) share are- Past 1 week: 2.44%
- Past 1 month: 1.36%
- Past 3 months: 33.70%
- Past 6 months: -13.32%
- Past 1 year: 3.48%
- Past 3 years: -71.30%
- Past 5 years: -55.61%
What are the peers or stocks similar to Nureca Ltd (NURECA)?
The peers or stocks similar to Nureca Ltd (NURECA) include:What is the market cap of Nureca Ltd (NURECA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nureca Ltd (NURECA) is ₹286.66 Cr as of 11th July 2025.What is the 52 week high and low of Nureca Ltd (NURECA) share?
The 52-week high of Nureca Ltd (NURECA) is ₹447.50 and the 52-week low is ₹203.62.What is the PE and PB ratio of Nureca Ltd (NURECA) stock?
The P/E (price-to-earnings) ratio of Nureca Ltd (NURECA) is 333.32. The P/B (price-to-book) ratio is 1.48.Which sector does Nureca Ltd (NURECA) belong to?
Nureca Ltd (NURECA) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Nureca Ltd (NURECA) shares?
You can directly buy Nureca Ltd (NURECA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Nureca Ltd
NURECA Share Price
NURECA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
NURECA Performance & Key Metrics
NURECA Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
353.90 | 1.48 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
36.72 | 6.42 | 0.79% |
NURECA Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
NURECA Company Profile
Nureca Ltd is engaged in the marketing of home healthcare & wellness products
NURECA Forecast
NURECA Forecasts
NURECA
NURECA
Income
Balance Sheet
Cash Flow
NURECA Income Statement
NURECA Income Statement
Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 20.07 | 61.99 | 99.49 | 216.27 | 263.25 | 118.43 | 102.44 | 122.10 | 122.09 | |||||||||
Raw Materials | 15.68 | 50.16 | 67.49 | 120.01 | 159.55 | 44.76 | 56.23 | 74.97 | 117.21 | |||||||||
Power & Fuel Cost | 0.02 | 0.04 | 0.01 | 0.16 | 0.20 | 0.13 | 0.18 | |||||||||||
Employee Cost | 0.89 | 3.16 | 4.58 | 9.91 | 16.06 | 12.20 | 15.31 | |||||||||||
Selling & Administrative Expenses | 11.12 | 19.66 | 44.81 | 51.71 | 30.34 | 24.91 | 30.25 | |||||||||||
Operating & Other expenses | -9.35 | -0.61 | -17.50 | -21.29 | 34.97 | 8.67 | -3.51 | |||||||||||
EBITDA | 4.39 | 9.15 | 9.75 | 64.36 | 63.21 | -7.90 | 0.30 | 4.90 | 4.88 | |||||||||
Depreciation/Amortization | 0.01 | 0.06 | 0.37 | 0.42 | 1.48 | 2.39 | 2.36 | 2.34 | 2.34 | |||||||||
PBIT | 4.38 | 9.09 | 9.38 | 63.94 | 61.73 | -10.29 | -2.06 | 2.56 | 2.54 | |||||||||
Interest & Other Items | 0.06 | 0.24 | 0.77 | 1.60 | 0.74 | 0.45 | 0.49 | 1.21 | 1.22 | |||||||||
PBT | 4.32 | 8.85 | 8.61 | 62.34 | 60.99 | -10.74 | -2.55 | 1.35 | 1.32 | |||||||||
Taxes & Other Items | 1.21 | 2.61 | 2.22 | 15.96 | 16.02 | -2.49 | -0.75 | 0.49 | 0.51 | |||||||||
Net Income | 3.11 | 6.24 | 6.39 | 46.38 | 44.97 | -8.25 | -1.80 | 0.86 | 0.81 | |||||||||
EPS | 0.64 | 891.43 | 912.86 | 92.11 | 44.97 | -8.25 | -1.80 | 0.86 | 0.81 | |||||||||
DPS | — | 0.00 | 0.00 | 2.00 | 3.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
NURECA Company Updates
NURECA Stock Peers
NURECA Past Performance & Peer Comparison
NURECA Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Nureca Ltd | 333.32 | 1.48 | — |
Sun Pharmaceutical Industries Ltd | 36.71 | 5.53 | 0.96% |
Cipla Ltd | 22.75 | 3.83 | 1.08% |
Torrent Pharmaceuticals Ltd | 58.69 | 14.78 | 0.18% |
NURECA Stock Price Comparison
Compare NURECA with any stock or ETFNURECA Holdings
NURECA Shareholdings
NURECA Promoter Holdings Trend
NURECA Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
NURECA Institutional Holdings Trend
NURECA Institutional Holdings Trend
In last 3 months, retail holding in the company has decreased by 3.12%
In last 3 months, foreign institutional holding of the company has almost stayed constant
NURECA Shareholding Pattern
NURECA Shareholding Pattern
NURECA Shareholding History
NURECA Shareholding History
smallcases containing NURECA stock
smallcases containing NURECA stock
Looks like this stock is not in any smallcase yet.
NURECA Events
NURECA Events
NURECA Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
NURECA Dividend Trend
No dividend trend available
NURECA Upcoming Dividends
NURECA Upcoming Dividends
No upcoming dividends are available
NURECA Past Dividends
NURECA Past Dividends
Cash Dividend
Ex DateEx DateFeb 24, 2022
Dividend/Share
₹3.00
Ex DateEx Date
Feb 24, 2022
Cash Dividend
Ex DateEx DateSep 21, 2021
Dividend/Share
₹2.00
Ex DateEx Date
Sep 21, 2021
NURECA Stock News & Opinions
NURECA Stock News & Opinions
Nureca will hold a meeting of the Board of Directors of the Company on 15 July 2025.Powered by Capital Market - Live
Nureca announced that the 9th Annual General Meeting(AGM) of the company will be held on 16 June 2025.Powered by Capital Market - Live
Net profit of Nureca reported to Rs 2.47 crore in the quarter ended March 2025 as against net loss of Rs 4.15 crore during the previous quarter ended March 2024. Sales rose 87.04% to Rs 31.74 crore in the quarter ended March 2025 as against Rs 16.97 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 0.85 crore in the year ended March 2025 as against net loss of Rs 1.79 crore during the previous year ended March 2024. Sales rose 19.29% to Rs 109.66 crore in the year ended March 2025 as against Rs 91.93 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales31.7416.97 87 109.6691.93 19 OPM %3.78-26.10 --6.88-11.10 - PBDT2.57-5.87 LP 3.68-0.18 LP PBT2.05-6.47 LP 1.34-2.54 LP NP2.47-4.15 LP 0.85-1.79 LP Powered by Capital Market - Live
Nureca will hold a meeting of the Board of Directors of the Company on 5 May 2025.Powered by Capital Market - Live
Net loss of Nureca reported to Rs 2.80 crore in the quarter ended December 2024 as against net profit of Rs 0.17 crore during the previous quarter ended December 2023. Sales rose 18.28% to Rs 26.46 crore in the quarter ended December 2024 as against Rs 22.37 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales26.4622.37 18 OPM %-15.19-19.00 - PBDT-2.711.54 PL PBT-3.250.95 PL NP-2.800.17 PL Powered by Capital Market - Live
Nureca will hold a meeting of the Board of Directors of the Company on 24 January 2025.Powered by Capital Market - Live
Net loss of Nureca reported to Rs 0.48 crore in the quarter ended September 2024 as against net profit of Rs 2.89 crore during the previous quarter ended September 2023. Sales declined 0.51% to Rs 31.19 crore in the quarter ended September 2024 as against Rs 31.35 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales31.1931.35 -1 OPM %-7.574.40 - PBDT0.554.50 -88 PBT-0.083.91 PL NP-0.482.89 PL Powered by Capital Market - Live
Nureca will hold a meeting of the Board of Directors of the Company on 24 October 2024.Powered by Capital Market - Live
Nureca reports consolidated net profit of Rs 1.66 crore in the June 2024 quarter

Net profit of Nureca reported to Rs 1.66 crore in the quarter ended June 2024 as against net loss of Rs 0.71 crore during the previous quarter ended June 2023. Sales declined 4.52% to Rs 20.27 crore in the quarter ended June 2024 as against Rs 21.23 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales20.2721.23 -5 OPM %-11.64-13.66 - PBDT3.28-0.35 LP PBT2.62-0.93 LP NP1.66-0.71 LP Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 4.18%, vs industry avg of 10%
Over the last 5 years, market share decreased from 0.04% to 0.03%
Over the last 5 years, net income has grown at a yearly rate of -33.04%, vs industry avg of 19.96%